blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3302469

EP3302469 - COMPOSITIONS AND METHODS FOR REDUCING VISUAL LOSS [Right-click to bookmark this link]
StatusThe application has been withdrawn
Status updated on  27.07.2018
Database last updated on 24.07.2024
FormerRequest for examination was made
Status updated on  09.03.2018
FormerThe international publication has been made
Status updated on  09.12.2016
Most recent event   Tooltip27.07.2018Withdrawal of applicationpublished on 29.08.2018  [2018/35]
Applicant(s)For all designated states
Edge Therapeutics, Inc.
200 Connell Drive Suite 1600
Berkeley Heights, NJ 07922 / US
[2018/15]
Inventor(s)01 / MACDONALD, R., Loch
20 Whitney Avenue
Toronto, ON M4W2A8 / CA
 [2018/15]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2018/15]J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date16803896.619.04.2016
[2018/15]
WO2016US28283
Priority number, dateUS201562168588P29.05.2015         Original published format: US 201562168588 P
[2018/15]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016195833
Date:08.12.2016
Language:EN
[2016/49]
Type: A1 Application with search report 
No.:EP3302469
Date:11.04.2018
Language:EN
The application published by WIPO in one of the EPO official languages on 08.12.2016 takes the place of the publication of the European patent application.
[2018/15]
Search report(s)International search report - published on:US08.12.2016
ClassificationIPC:A61K31/4422, A61K9/08, A61P27/06
[2018/15]
CPC:
A61K9/0051 (EP,GB,KR,US); A61K31/4422 (EP,GB,KR,US); A61K9/0048 (EP,GB,KR,US);
A61K31/5575 (EP,GB,KR,US); A61K45/06 (EP,GB,KR,US); A61K9/08 (GB);
A61K9/1647 (EP,GB,KR,US); A61P27/02 (EP,KR); A61P27/06 (EP,GB,KR);
A61P27/10 (EP); A61P43/00 (EP); A61K2300/00 (KR) (-)
C-Set:
A61K31/4422, A61K2300/00 (EP,US);
A61K31/5575, A61K2300/00 (US,EP)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/15]
Extension statesBANot yet paid
MENot yet paid
Validation statesMANot yet paid
MDNot yet paid
TitleGerman:ZUSAMMENSETZUNGEN UND VERFAHREN ZUR VERRINGERUNG DES SEHKRAFTVERLUSTES[2018/15]
English:COMPOSITIONS AND METHODS FOR REDUCING VISUAL LOSS[2018/15]
French:COMPOSITIONS ET MÉTHODES POUR DIMINUER UNE PERTE DE LA VISION[2018/15]
Entry into regional phase22.12.2017National basic fee paid 
22.12.2017Search fee paid 
22.12.2017Designation fee(s) paid 
22.12.2017Examination fee paid 
Examination procedure22.12.2017Examination requested  [2018/15]
22.12.2017Date on which the examining division has become responsible
24.07.2018Application withdrawn by applicant  [2018/35]
Fees paidRenewal fee
27.04.2018Renewal fee patent year 03
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[A]US2009104248  (RAPACKI ALAN R [US], et al) [A] 1-22* Entire Document *;
 [Y]US2010106128  (MAO SHANE [US], et al) [Y] 14-22 * para [0036], [0039], [0040], [0052], [0056] *;
 [Y]US2011294730  (SHANTHA TOTADA R [US], et al) [Y] 3 * para [0072] *;
 [Y]US2013289467  (HAFFNER DAVID [US], et al) [Y] 1-22 * para [0017]-[0018], [0021], [0070], [0286], [0300], [0309], [0312], [0332], [0362], [[0366], *;
 [Y]US2013302431  (MACDONALD R LOCH [CA], et al) [Y] 1-22 * [0039], [0199], [0212] *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.